reaction_smiles,sources,reactants,products,solvents,catalyst,stages
"['[Cl:1][C:2]1[CH:27]=[CH:26][C:5]([CH2:6][N:7]2[C:19]3[C@@H:18]([CH2:20][C:21]([OH:23])=[O:22])[CH2:17][CH2:16][CH2:15][C:14]=3[C:13]3[C:8]2=[C:9]([S:24][CH3:25])[CH:10]=[CH:11][CH:12]=3)=[CH:4][CH:3]=1.[N+](=[CH2:30])=[N-]', 'CC(C)=O', '[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([CH2:6][N:7]2[C:19]3[C@@H:18]([CH2:20][C:21]([O:23][CH3:30])=[O:22])[CH2:17][CH2:16][CH2:15][C:14]=3[C:13]3[C:8]2=[C:9]([S:24][CH3:25])[CH:10]=[CH:11][CH:12]=3)=[CH:26][CH:27]=1']","['US20010047027A1', 'Step f. methyl 2-[(1R)-9-(4-chlorobenzyl)-8-(methylsulfanyl)-2,3,4,9-tetrahydro-1H-carbazol-1-yl]acetate', '0058', 'The acid of step e (8.0 g, 20.0 mmol) was dissolved in acetone (250 mL) and treated with diazomethane (approximately 2M solution in diethyl ether) until yellow color remained. Excess CH2N2 was quenched with acetic acid, and the reaction mixture was concentrated to dryness to afford a yellow oil (8.3 g). (100%).']","[{'chemical_names': ['acid', '2-[(1R)-9-(4-chlorobenzyl)-8-(methylsulfanyl)-2,3,4,9-tetrahydro-1H-carbazol-1-yl]acetic acid'], 'identifiers': ['smiles:CSc1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CCC3', 'inchi:InChI=1S/C22H22ClNO2S/c1-27-19-7-3-6-18-17-5-2-4-15(12-20(25)26)21(17)24(22(18)19)13-14-8-10-16(23)11-9-14/h3,6-11,15H,2,4-5,12-13H2,1H3,(H,25,26)/t15-/m1/s1'], 'amounts': ['20.0 mmol', '8.0 g'], 'appearances': []}, {'chemical_names': ['diazomethane'], 'identifiers': ['smiles:C=[N+]=[N-]', 'inchi:InChI=1S/CH2N2/c1-3-2/h1H2'], 'amounts': ['approximately 2M'], 'appearances': []}]","[{'chemical_names': ['oil', 'methyl 2-[(1R)-9-(4-chlorobenzyl)-8-(methylsulfanyl)-2,3,4,9-tetrahydro-1H-carbazol-1-yl]acetate'], 'identifiers': ['smiles:COC(=O)C[C@H]1CCCc2c1n(Cc1ccc(Cl)cc1)c1c(SC)cccc21', 'inchi:InChI=1S/C23H24ClNO2S/c1-27-21(26)13-16-5-3-6-18-19-7-4-8-20(28-2)23(19)25(22(16)18)14-15-9-11-17(24)12-10-15/h4,7-12,16H,3,5-6,13-14H2,1-2H3/t16-/m1/s1'], 'amounts': ['8.3 g'], 'appearances': []}]","[{'chemical_names': ['acetone'], 'identifiers': ['smiles:CC(C)=O', 'inchi:InChI=1S/C3H6O/c1-3(2)4/h1-2H3'], 'amounts': ['250 mL'], 'appearances': []}]",[],"['step 1:The acid of step e (8.0 g, 20.0 mmol) was dissolved in acetone (250 mL)', 'step 2:treated with diazomethane (approximately 2M solution in diethyl ether) until yellow color', 'step 3:Excess CH2N2 was quenched with acetic acid', 'step 4:the reaction mixture was concentrated to dryness', 'step 5:to afford a yellow oil (8.3 g)']"
"['[C:1]([O:5][C:6]([N:8]1[CH2:12][CH:11]([S:13][C:14]2[CH:19]=[CH:18][C:17]([OH:20])=[CH:16][CH:15]=2)[CH:10]([OH:21])[CH2:9]1)=[O:7])([CH3:4])([CH3:3])[CH3:2].C([O-])([O-])=O.[K+].[K+].[CH2:28](Br)[C:29]1[CH:34]=[CH:33][CH:32]=[CH:31][CH:30]=1', 'CC(C)=O', '[C:1]([O:5][C:6]([N:8]1[CH2:9][CH:10]([OH:21])[CH:11]([S:13][C:14]2[CH:15]=[CH:16][C:17]([O:20][CH2:28][C:29]3[CH:34]=[CH:33][CH:32]=[CH:31][CH:30]=3)=[CH:18][CH:19]=2)[CH2:12]1)=[O:7])([CH3:4])([CH3:2])[CH3:3] |f:1.2.3|']","['US20010047031A1', '0246', '(3RS, 4RS)-3-Hydroxy-4-(4-hydroxy-phenylsulfanyl)-pyrrolidine-1-carboxylic acid tert-butyl ester (0.2 g, 0.6 mmol) was dissolved in acetone (5 ml), and treated with K2CO3 (0.1 g, 0.7 mmol). After 1 hour refluxing, the reaction mixture was cooled to room temperature and benzylbromide (0.084 ml, 0.7 mmol) was added. Reaction mixture was refluxed for an additional 3 hours then cooled to room temperature and quenched with H2O. The aqueous phase was extracted with CH2Cl2, the combined organic phases were dried over Na2SO4, filtered and the solvent was evaporated. The residue was chromatographed over silica gel (hexane-ethyl acetate 2:1) to provide (3RS, 4RS)-3-(4-benzyloxy-phenylsulfanyl)-4-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester (0.208 g, 81%) as a yellow oil, MS: m/e=402.4 (M+H+).']","[{'chemical_names': ['(3RS, 4RS)-3-Hydroxy-4-(4-hydroxy-phenylsulfanyl)-pyrrolidine-1-carboxylic acid tert-butyl ester'], 'identifiers': ['smiles:CC(C)(C)OC(=O)N1CC(O)C(Sc2ccc(O)cc2)C1', 'inchi:InChI=1S/C15H21NO4S/c1-15(2,3)20-14(19)16-8-12(18)13(9-16)21-11-6-4-10(17)5-7-11/h4-7,12-13,17-18H,8-9H2,1-3H3'], 'amounts': ['0.6 mmol', '0.2 g'], 'appearances': []}, {'chemical_names': ['K2CO3'], 'identifiers': ['smiles:O=C([O-])[O-].[K+].[K+]', 'inchi:InChI=1S/CH2O3.2K/c2-1(3)4;;/h(H2,2,3,4);;/q;2*+1/p-2'], 'amounts': ['0.7 mmol', '0.1 g'], 'appearances': []}, {'chemical_names': ['benzylbromide'], 'identifiers': ['smiles:BrCc1ccccc1', 'inchi:InChI=1S/C7H7Br/c8-6-7-4-2-1-3-5-7/h1-5H,6H2'], 'amounts': ['0.7 mmol', '0.084 ml'], 'appearances': []}]","[{'chemical_names': ['(3RS, 4RS)-3-(4-benzyloxy-phenylsulfanyl)-4-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester'], 'identifiers': ['smiles:CC(C)(C)OC(=O)N1CC(O)C(Sc2ccc(OCc3ccccc3)cc2)C1', 'inchi:InChI=1S/C22H27NO4S/c1-22(2,3)27-21(25)23-13-19(24)20(14-23)28-18-11-9-17(10-12-18)26-15-16-7-5-4-6-8-16/h4-12,19-20,24H,13-15H2,1-3H3'], 'amounts': ['0.208 g', '81%', '86.3'], 'appearances': ['yellow']}]","[{'chemical_names': ['acetone'], 'identifiers': ['smiles:CC(C)=O', 'inchi:InChI=1S/C3H6O/c1-3(2)4/h1-2H3'], 'amounts': ['5 ml'], 'appearances': []}]",[],"['step 1:(3RS, 4RS)-3-Hydroxy-4-(4-hydroxy-phenylsulfanyl)-pyrrolidine-1-carboxylic acid tert-butyl ester (0.2 g, 0.6 mmol) was dissolved in acetone (5 ml)', 'step 2:treated with K2CO3 (0.1 g, 0.7 mmol)', 'step 3:After 1 hour refluxing', 'step 3 properties:Time:3600', 'step 4:the reaction mixture was cooled to room temperature', 'step 4 properties:Temperature:room temperature', 'step 5:benzylbromide (0.084 ml, 0.7 mmol) was added', 'step 6:Reaction mixture', 'step 7:was refluxed for an additional 3 hours', 'step 7 properties:Time:10800', 'step 8:then cooled to room temperature', 'step 8 properties:Temperature:room temperature', 'step 9:quenched with H2O', 'step 10:The aqueous phase was extracted with CH2Cl2', 'step 11:the combined organic phases were dried over Na2SO4', 'step 12:filtered', 'step 13:the solvent was evaporated', 'step 14:The residue was chromatographed over silica gel (hexane-ethyl acetate 2:1)', 'step 15:to provide (3RS, 4RS)-3-(4-benzyloxy-phenylsulfanyl)-4-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester (0.208 g, 81%) as a yellow oil, MS']"
"['[CH3:1][CH2:2][C@H:3]1[O:18][C:16](=[O:17])[C@H:15]([CH3:19])[C@@H:14]([O:20][C@@H:21]2[O:26][C@@H:25]([CH3:27])[C@H:24]([OH:28])[C@@:23]([O:30][CH3:31])([CH3:29])[CH2:22]2)[C@H:13]([CH3:32])[C@@H:12]([O:33][C@@H:34]2[O:39][C@H:38]([CH3:40])[CH2:37][C@H:36]([N:41]([CH3:43])[CH3:42])[C@H:35]2[OH:44])[C@@:11]([OH:46])([CH3:45])[CH2:10][C@@H:9]([CH3:47])[CH2:8][NH:7][C@H:6]([CH3:48])[C@@H:5]([OH:49])[C@@:4]1([OH:51])[CH3:50].C=O.[CH:54](O)=O.O', 'CC(C)=O', '[CH3:1][CH2:2][C@H:3]1[O:18][C:16](=[O:17])[C@H:15]([CH3:19])[C@@H:14]([O:20][C@@H:21]2[O:26][C@@H:25]([CH3:27])[C@H:24]([OH:28])[C@@:23]([O:30][CH3:31])([CH3:29])[CH2:22]2)[C@H:13]([CH3:32])[C@@H:12]([O:33][C@@H:34]2[O:39][C@H:38]([CH3:40])[CH2:37][C@H:36]([N:41]([CH3:43])[CH3:42])[C@H:35]2[OH:44])[C@@:11]([OH:46])([CH3:45])[CH2:10][C@@H:9]([CH3:47])[CH2:8][N:7]([CH3:54])[C@H:6]([CH3:48])[C@@H:5]([OH:49])[C@@:4]1([OH:51])[CH3:50]']","['US20010047089A1', '0022', 'By the methods of the present invention, desmethyl-azithromycin is dissolved in acetone. Formaldehyde and formic acid are added to the solution and the clear solution is heated to reflux (˜58° C.). The mixture is maintained under reflux for about 3 hours then cooled to less than about 40° C. Water is added and the acetone is separated from the reaction mixture by distillation under low vacuum (˜300 mbar). The distillation is stopped when the temperature of the liquid phase reaches ˜40° C./300 mbar. Activated carbon SXI is added and the suspension is mixed for about 1 hour. The activated carbon is then separated from the solution by filtration on a Büchner filter containing Hyflow. The filter cake is washed with water. The pH is adjusted with an NaOH to about 10-10.5 to induce precipitation of azithromycin. The azithromycin suspension is stirred for about 1 hour. The crude azithromycin crude is separated by filtration and washed. Azithromycin is isolated upon drying the filtrate 40° C. in a vacuum oven. Preferably the azithromycin is dried for at least 24 hours. No impurities were detected that were derivatives of azithromycin in the isolated azithromycin Azithromycin dihydrate prepared in accordance with the present invention is suitable formulation and administration for the treatment of susceptible bacterial infections in humans according to the methods and in the amounts set forth in U.S. Pat. No. 4,474,768, cited above.']","[{'chemical_names': ['desmethyl-azithromycin'], 'identifiers': ['smiles:CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN[C@H](C)[C@@H](O)[C@]1(C)O', 'inchi:InChI=1S/C37H70N2O12/c1-14-26-37(10,45)30(41)23(6)38-18-19(2)16-35(8,44)32(51-34-28(40)25(39(11)12)15-20(3)47-34)21(4)29(22(5)33(43)49-26)50-27-17-36(9,46-13)31(42)24(7)48-27/h19-32,34,38,40-42,44-45H,14-18H2,1-13H3/t19-,20-,21+,22-,23-,24+,25+,26-,27+,28-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1'], 'amounts': [], 'appearances': []}, {'chemical_names': ['Formaldehyde'], 'identifiers': ['smiles:C=O', 'inchi:InChI=1S/CH2O/c1-2/h1H2'], 'amounts': [], 'appearances': []}, {'chemical_names': ['formic acid'], 'identifiers': ['smiles:O=CO', 'inchi:InChI=1S/CH2O2/c2-1-3/h1H,(H,2,3)'], 'amounts': [], 'appearances': []}, {'chemical_names': ['Water'], 'identifiers': ['smiles:O', 'inchi:InChI=1S/H2O/h1H2'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['Azithromycin'], 'identifiers': ['smiles:CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O', 'inchi:InChI=1S/C38H72N2O12/c1-15-27-38(10,46)31(42)24(6)40(13)19-20(2)17-36(8,45)33(52-35-29(41)26(39(11)12)16-21(3)48-35)22(4)30(23(5)34(44)50-27)51-28-18-37(9,47-14)32(43)25(7)49-28/h20-33,35,41-43,45-46H,15-19H2,1-14H3/t20-,21-,22+,23-,24-,25+,26+,27-,28+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['acetone'], 'identifiers': ['smiles:CC(C)=O', 'inchi:InChI=1S/C3H6O/c1-3(2)4/h1-2H3'], 'amounts': [], 'appearances': []}]",[],"['step 1:By the methods of the present invention, desmethyl-azithromycin is dissolved in acetone', 'step 2:Formaldehyde and formic acid are added to the solution', 'step 3:the clear solution is heated', 'step 4:to reflux (˜58° C.)', 'step 4 properties:Temperature:~58', 'step 5:The mixture is maintained', 'step 6:under reflux for about 3 hours', 'step 6 properties:Time:~10800', 'step 7:then cooled to less than about 40° C', 'step 7 properties:Temperature:<~40', 'step 8:Water is added', 'step 9:the acetone is separated from the reaction mixture by distillation under low vacuum (˜300 mbar)', 'step 9 properties:Pressure:~30000', 'step 10:The distillation', 'step 11:reaches ˜40° C.', 'step 11 properties:Temperature:~40', 'step 12:Activated carbon SXI is added', 'step 13:the suspension is mixed for about 1 hour', 'step 13 properties:Time:~3600', 'step 14:The activated carbon is then separated from the solution by filtration on a Büchner', 'step 15:filter', 'step 16:containing Hyflow', 'step 17:The filter cake is washed with water', 'step 18:precipitation of azithromycin', 'step 19:The azithromycin suspension is stirred for about 1 hour', 'step 19 properties:Time:~3600', 'step 20:The crude azithromycin crude is separated by filtration', 'step 21:washed', 'step 22:Azithromycin is isolated']"
"['[CH3:1][CH2:2][C@H:3]1[O:18][C:16](=[O:17])[C@H:15]([CH3:19])[C@@H:14]([O:20][C@@H:21]2[O:26][C@@H:25]([CH3:27])[C@H:24]([OH:28])[C@@:23]([O:30][CH3:31])([CH3:29])[CH2:22]2)[C@H:13]([CH3:32])[C@@H:12]([O:33][C@@H:34]2[O:39][C@H:38]([CH3:40])[CH2:37][C@H:36]([N:41]([CH3:43])[CH3:42])[C@H:35]2[OH:44])[C@@:11]([OH:46])([CH3:45])[CH2:10][C@@H:9]([CH3:47])[CH2:8][NH:7][C@H:6]([CH3:48])[C@@H:5]([OH:49])[C@@:4]1([OH:51])[CH3:50].C=O.[CH:54](O)=O.O', 'CC(C)=O', '[CH3:1][CH2:2][C@H:3]1[O:18][C:16](=[O:17])[C@H:15]([CH3:19])[C@@H:14]([O:20][C@@H:21]2[O:26][C@@H:25]([CH3:27])[C@H:24]([OH:28])[C@@:23]([O:30][CH3:31])([CH3:29])[CH2:22]2)[C@H:13]([CH3:32])[C@@H:12]([O:33][C@@H:34]2[O:39][C@H:38]([CH3:40])[CH2:37][C@H:36]([N:41]([CH3:43])[CH3:42])[C@H:35]2[OH:44])[C@@:11]([OH:46])([CH3:45])[CH2:10][C@@H:9]([CH3:47])[CH2:8][N:7]([CH3:54])[C@H:6]([CH3:48])[C@@H:5]([OH:49])[C@@:4]1([OH:51])[CH3:50]']","['US20010047089A1', '0025', 'In a 0.25 L three-necked round bottom flask equipped with a mechanical stirrer, a condenser and thermometer, 25 g of desmethyl-azithromycin was dissolved in 102 mL of acetone. Formaldehyde (5.3 mL) and formic acid (2.6 mL) were added and the clear solution was heated to reflux (˜58° C.). The mixture was maintained under reflux for 3 hours then cooled to less than 40° C. and 102 mL of water was added. The acetone was separated from the reaction mixture by distillation under low vacuum (˜300 mbar). The distillation was stopped when the temperature of the liquid phase reaches ˜40° C./300 mbar. Activated carbon SXI (1.25 g) was added and the suspension was mixed for 1 hour. Then the activated carbon was separated from the solution by filtration on a Büchner filter containing Hyflow. The filter cake was washed with 102 mL of water. The pH was adjusted with an NaOH solution of 47% to 10-10.5 (˜3.14 g). A massive precipitation of Azithromycin was observed. After stirring the suspension for 1 hour, the crude azithromycin was separated by filtration, washed twice with 25 mL of water and dried at 40° C. in a vacuum oven for>24 hours. After drying, 19.7 g of crude azithromycin was obtained (yield 77% based on weight). No impurities that were derivatives of azithromycin were detected.']","[{'chemical_names': ['desmethyl-azithromycin'], 'identifiers': ['smiles:CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN[C@H](C)[C@@H](O)[C@]1(C)O', 'inchi:InChI=1S/C37H70N2O12/c1-14-26-37(10,45)30(41)23(6)38-18-19(2)16-35(8,44)32(51-34-28(40)25(39(11)12)15-20(3)47-34)21(4)29(22(5)33(43)49-26)50-27-17-36(9,46-13)31(42)24(7)48-27/h19-32,34,38,40-42,44-45H,14-18H2,1-13H3/t19-,20-,21+,22-,23-,24+,25+,26-,27+,28-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1'], 'amounts': ['25 g'], 'appearances': []}, {'chemical_names': ['Formaldehyde'], 'identifiers': ['smiles:C=O', 'inchi:InChI=1S/CH2O/c1-2/h1H2'], 'amounts': ['5.3 mL'], 'appearances': []}, {'chemical_names': ['formic acid'], 'identifiers': ['smiles:O=CO', 'inchi:InChI=1S/CH2O2/c2-1-3/h1H,(H,2,3)'], 'amounts': ['2.6 mL'], 'appearances': []}, {'chemical_names': ['water'], 'identifiers': ['smiles:O', 'inchi:InChI=1S/H2O/h1H2'], 'amounts': ['102 mL'], 'appearances': []}]","[{'chemical_names': ['azithromycin'], 'identifiers': ['smiles:CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O', 'inchi:InChI=1S/C38H72N2O12/c1-15-27-38(10,46)31(42)24(6)40(13)19-20(2)17-36(8,45)33(52-35-29(41)26(39(11)12)16-21(3)48-35)22(4)30(23(5)34(44)50-27)51-28-18-37(9,47-14)32(43)25(7)49-28/h20-33,35,41-43,45-46H,15-19H2,1-14H3/t20-,21-,22+,23-,24-,25+,26+,27-,28+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1'], 'amounts': ['19.7 g', 'yield 77%'], 'appearances': []}]","[{'chemical_names': ['acetone'], 'identifiers': ['smiles:CC(C)=O', 'inchi:InChI=1S/C3H6O/c1-3(2)4/h1-2H3'], 'amounts': ['102 mL'], 'appearances': []}]",[],"['step 1:In a 0.25 L three-necked round bottom flask equipped with a mechanical stirrer, a condenser', 'step 2:thermometer, 25 g of desmethyl-azithromycin was dissolved in 102 mL of acetone', 'step 3:Formaldehyde (5.3 mL) and formic acid (2.6 mL) were added', 'step 4:the clear solution was heated', 'step 5:to reflux (˜58° C.)', 'step 5 properties:Temperature:~58', 'step 6:The mixture was maintained', 'step 7:under reflux for 3 hours', 'step 7 properties:Time:10800', 'step 8:then cooled to less than 40° C.', 'step 8 properties:Temperature:<40', 'step 9:102 mL of water was added', 'step 10:The acetone was separated from the reaction mixture by distillation under low vacuum (˜300 mbar)', 'step 10 properties:Pressure:~30000', 'step 11:The distillation', 'step 12:reaches ˜40° C.', 'step 12 properties:Temperature:~40', 'step 13:Activated carbon SXI (1.25 g) was added', 'step 14:the suspension was mixed for 1 hour', 'step 14 properties:Time:3600', 'step 15:Then the activated carbon was separated from the solution by filtration on a Büchner', 'step 16:filter', 'step 17:containing Hyflow', 'step 18:The filter cake was washed with 102 mL of water', 'step 19:A massive precipitation of Azithromycin', 'step 20:After stirring the suspension for 1 hour', 'step 20 properties:Time:3600', 'step 21:the crude azithromycin was separated by filtration', 'step 22:washed twice with 25 mL of water', 'step 23:dried at 40° C. in a vacuum oven for>24 hours', 'step 23 properties:Time:86400', 'step 23 properties:Temperature:40', 'step 24:After drying', 'step 25:19.7 g of crude azithromycin was obtained (yield 77% based on weight)']"
"['[Br:1][C:2]1[CH:7]=[C:6]([Br:8])[N:5]=[C:4]([C:9]([O:11][CH3:12])=[O:10])[C:3]=1[OH:13].[C:14]([O-])([O-])=O.[K+].[K+].S(OC)(OC)(=O)=O', 'CC(C)=O', '[Br:1][C:2]1[CH:7]=[C:6]([Br:8])[N:5]=[C:4]([C:9]([O:11][CH3:12])=[O:10])[C:3]=1[O:13][CH3:14] |f:1.2.3|']","['US20010047099A1', 'A. Methyl 4,6-dibromo-3-methoxypyridine-2-carboxylate', '0155', 'To methyl 4,6-dibromo-3-hydroxypyridine-2-carboxylate 3.98 g (3.98 g, 12.81 mmol) in 40 mL of acetone was added K2CO3 (2.0 g, 14.47 mmol) and dimethyl sulfate (1.20 mL, 12.37 mmol). The reaction mixture was refluxed overnight and concentrated to dryness. The residue was dissolved in ethyl acetate and saturated sodium bicarbonate. The phases were separated and the aqueous phase was extracted with ethyl acetate (3×100 mL). The combined extracts were dried (MgSO4) and concentrated to dryness. The residue was purified by chromatography (silica gel). Elution with 15% ethyl acetate/hexane gave 0.980 g, of a white solid. 1H NMR(CDCl3): δ 3.95 (s, 3H); 3.90 (s, 3H); 7.80 (s, 1H).']","[{'chemical_names': ['methyl 4,6-dibromo-3-hydroxypyridine-2-carboxylate'], 'identifiers': ['smiles:COC(=O)c1nc(Br)cc(Br)c1O', 'inchi:InChI=1S/C7H5Br2NO3/c1-13-7(12)5-6(11)3(8)2-4(9)10-5/h2,11H,1H3'], 'amounts': ['12.81 mmol', '3.98 g'], 'appearances': []}, {'chemical_names': ['K2CO3'], 'identifiers': ['smiles:O=C([O-])[O-].[K+].[K+]', 'inchi:InChI=1S/CH2O3.2K/c2-1(3)4;;/h(H2,2,3,4);;/q;2*+1/p-2'], 'amounts': ['14.47 mmol', '2.0 g'], 'appearances': []}, {'chemical_names': ['dimethyl sulfate'], 'identifiers': ['smiles:COS(=O)(=O)OC', 'inchi:InChI=1S/C2H6O4S/c1-5-7(3,4)6-2/h1-2H3'], 'amounts': ['12.37 mmol', '1.20 mL'], 'appearances': []}]","[{'chemical_names': ['Methyl 4,6-dibromo-3-methoxypyridine-2-carboxylate'], 'identifiers': ['smiles:COC(=O)c1nc(Br)cc(Br)c1OC', 'inchi:InChI=1S/C8H7Br2NO3/c1-13-7-4(9)3-5(10)11-6(7)8(12)14-2/h3H,1-2H3'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['acetone'], 'identifiers': ['smiles:CC(C)=O', 'inchi:InChI=1S/C3H6O/c1-3(2)4/h1-2H3'], 'amounts': ['40 mL'], 'appearances': []}]",[],"['step 1:To methyl 4,6-dibromo-3-hydroxypyridine-2-carboxylate 3.98 g (3.98 g, 12.81 mmol) in 40 mL of acetone was added K2CO3 (2.0 g, 14.47 mmol) and dimethyl sulfate (1.20 mL, 12.37 mmol)', 'step 2:The reaction mixture was refluxed overnight', 'step 2 properties:Time:overnight', 'step 3:concentrated to dryness', 'step 4:The residue was dissolved in ethyl acetate', 'step 5:The phases were separated', 'step 6:the aqueous phase was extracted with ethyl acetate (3×100 mL)', 'step 7:The combined extracts were dried (MgSO4)', 'step 8:concentrated to dryness', 'step 9:The residue was purified by chromatography (silica gel)', 'step 10:Elution with 15% ethyl acetate/hexane', 'step 11:gave 0.980 g']"
"['[Cl:1][C:2]1[CH:19]=[CH:18][CH:17]=[C:16]([Si:20]([CH3:23])([CH3:22])[CH3:21])[C:3]=1[C:4]([N:6](CC)[CH:7](OC)[C:8](C)(C)C)=[O:5].CN(CCN(C)C)C.[Li]C(CC)C.C1CCCCC1.[Br:43]CCBr', 'C1COCC1.CC(C)=O.Cl', '[Br:43][C:19]1[C:2]([Cl:1])=[C:3]([C:16]([Si:20]([CH3:23])([CH3:22])[CH3:21])=[CH:17][CH:18]=1)[C:4]([NH:6][CH2:7][CH3:8])=[O:5]']","['US20010046975A1', '3-Bromo-2-chloro-N-ethyl-6-(trimethylsilyl)benzamide', '0309', 'To a solution of the compound of Example 201 (0.79 g, 2.2 mmol) and TMEDA (0.44 mL, 2.9 mmol) in THF (20 mL) at −78° C. was added a solution of 0.86 M s-BuLi in cyclohexane (3.3 mL, 2.9 mmol). The reaction was stirred at −78° C. for 30 min and 1,2-dibromoethane (0.26 mL, 3.0 mmol) was added. The reaction was stirred for 15 min at −78° C. and was quenched with sat NaHCO3. The mixture was extracted with ether, washed with brine, dried (MgSO4 ) and concentrated to afford a yellow oil. This oil was dissolved in a mixture of acetone (30 mL) and 6 N HCl (15 mL) and was stirred overnight. The mixture was concentrated, extracted with ether, the organic layers washed with brine, dried (MgSO4) and concentrated to afford the title compound as a clear oil. The crude product was purified by RC (ethyl acetate/hexanes) and was recrystallized from pentane (−78° C.) to afford 76 mg of a white solid (10% yield). m.p. 105-106° C.']","[{'chemical_names': ['compound', '2-Chloro-N-ethyl-N-(1-methoxy-2,2-dimethylpropyl)-6-(trimethylsilyl)benzamide'], 'identifiers': ['smiles:CCN(C(=O)c1c(Cl)cccc1[Si](C)(C)C)C(OC)C(C)(C)C', 'inchi:InChI=1S/C18H30ClNO2Si/c1-9-20(17(22-5)18(2,3)4)16(21)15-13(19)11-10-12-14(15)23(6,7)8/h10-12,17H,9H2,1-8H3'], 'amounts': ['2.2 mmol', '0.79 g'], 'appearances': []}, {'chemical_names': ['TMEDA'], 'identifiers': ['smiles:CN(C)CCN(C)C', 'inchi:InChI=1S/C6H16N2/c1-7(2)5-6-8(3)4/h5-6H2,1-4H3'], 'amounts': ['2.9 mmol', '0.44 mL'], 'appearances': []}, {'chemical_names': ['s-BuLi'], 'identifiers': ['smiles:[Li]C(C)CC', 'inchi:InChI=1S/C4H9.Li/c1-3-4-2;/h3H,4H2,1-2H3;'], 'amounts': ['0.86 M'], 'appearances': []}, {'chemical_names': ['cyclohexane'], 'identifiers': ['smiles:C1CCCCC1', 'inchi:InChI=1S/C6H12/c1-2-4-6-5-3-1/h1-6H2'], 'amounts': ['2.9 mmol', '3.3 mL'], 'appearances': []}, {'chemical_names': ['1,2-dibromoethane'], 'identifiers': ['smiles:BrCCBr', 'inchi:InChI=1S/C2H4Br2/c3-1-2-4/h1-2H2'], 'amounts': ['3.0 mmol', '0.26 mL'], 'appearances': []}]","[{'chemical_names': ['title compound', '3-Bromo-2-chloro-N-ethyl-6-(trimethylsilyl)benzamide'], 'identifiers': ['smiles:CCNC(=O)c1c([Si](C)(C)C)ccc(Br)c1Cl', 'inchi:InChI=1S/C12H17BrClNOSi/c1-5-15-12(16)10-9(17(2,3)4)7-6-8(13)11(10)14/h6-7H,5H2,1-4H3,(H,15,16)'], 'amounts': [], 'appearances': ['clear']}]","[{'chemical_names': ['THF'], 'identifiers': ['smiles:C1CCOC1', 'inchi:InChI=1S/C4H8O/c1-2-4-5-3-1/h1-4H2'], 'amounts': ['20 mL'], 'appearances': []}, {'chemical_names': ['acetone'], 'identifiers': ['smiles:CC(C)=O', 'inchi:InChI=1S/C3H6O/c1-3(2)4/h1-2H3'], 'amounts': ['30 mL'], 'appearances': []}, {'chemical_names': ['HCl'], 'identifiers': ['smiles:Cl', 'inchi:InChI=1S/ClH/h1H'], 'amounts': ['6 N', '15 mL'], 'appearances': []}]",[],"['step 1:To a solution of the compound of Example 201 (0.79 g, 2.2 mmol) and TMEDA (0.44 mL, 2.9 mmol) in THF (20 mL) at −78° C. was added a solution of 0.86 M s-BuLi in cyclohexane (3.3 mL, 2.9 mmol)', 'step 1 properties:Temperature:-78', 'step 2:The reaction was stirred at −78° C. for 30 min', 'step 2 properties:Time:1800', 'step 2 properties:Temperature:-78', 'step 3:1,2-dibromoethane (0.26 mL, 3.0 mmol) was added', 'step 4:The reaction was stirred for 15 min at −78° C.', 'step 4 properties:Time:900', 'step 4 properties:Temperature:-78', 'step 5:was quenched with sat NaHCO3', 'step 6:The mixture was extracted with ether', 'step 7:washed with brine', 'step 8:dried (MgSO4 )', 'step 9:concentrated', 'step 10:to afford a yellow oil', 'step 11:This oil was dissolved in a mixture of acetone (30 mL) and 6 N HCl (15 mL)', 'step 12:was stirred overnight', 'step 12 properties:Time:overnight', 'step 13:The mixture was concentrated', 'step 14:extracted with ether', 'step 15:the organic layers washed with brine', 'step 16:dried (MgSO4)', 'step 17:concentrated', 'step 18:to afford the title compound as a clear oil']"
"['[CH2:1]([NH:3][C:4]([C:6]1[S:7][C:8]([S:15]([CH3:17])=O)=[CH:9][C:10]=1[Si:11]([CH3:14])([CH3:13])[CH3:12])=[O:5])[CH3:2].[Na+].[I-].FC(F)(F)C(OC(=O)C(F)(F)F)=O.S(S([O-])=O)([O-])(=O)=O.[Na+].[Na+]', 'CC(C)=O.C(Cl)Cl', '[CH2:1]([NH:3][C:4]([C:6]1[S:7][C:8]([S:15][CH3:17])=[CH:9][C:10]=1[Si:11]([CH3:14])([CH3:13])[CH3:12])=[O:5])[CH3:2] |f:1.2,4.5.6|']","['US20010046975A1', 'N-Ethyl-5-(methylthio)-3-(trimethylsilyl)-2-thiophenecarboxamide', '0370', 'To a solution of the compound of Example 260 (0.6 g) and NaI (0.8 g) in 10 mL acetone was added slowly 0.4 mL trifluoroacetic anhydride at 0° C. and the mixture was stirred at 0° C. for an additional hour. Then CH2Cl2 and aq sat sodium meta-bisulfite were added. The organic layer was separated, washed with brine, dried and concentrated. Flash chromatography of the residue with 10% ethyl acetate-hexane gave 0.5 g of the title compound as a white solid. m.p. 58-61° C.']","[{'chemical_names': ['compound', 'N-Ethyl-5-(methylsulfinyl)-3-(trimethylsilyl)-2-thiophenecarboxamide'], 'identifiers': ['smiles:CCNC(=O)c1sc(S(C)=O)cc1[Si](C)(C)C', 'inchi:InChI=1S/C11H19NO2S2Si/c1-6-12-11(13)10-8(17(3,4)5)7-9(15-10)16(2)14/h7H,6H2,1-5H3,(H,12,13)'], 'amounts': ['0.6 g'], 'appearances': []}, {'chemical_names': ['NaI'], 'identifiers': ['smiles:[I-].[Na+]', 'inchi:InChI=1S/HI.Na/h1H;/q;+1/p-1'], 'amounts': ['0.8 g'], 'appearances': []}, {'chemical_names': ['trifluoroacetic anhydride'], 'identifiers': ['smiles:O=C(OC(=O)C(F)(F)F)C(F)(F)F', 'inchi:InChI=1S/C4F6O3/c5-3(6,7)1(11)13-2(12)4(8,9)10'], 'amounts': ['0.4 mL'], 'appearances': []}, {'chemical_names': ['sodium meta-bisulfite'], 'identifiers': ['smiles:O=S([O-])S(=O)(=O)[O-].[Na+].[Na+]', 'inchi:InChI=1S/2Na.H2O5S2/c;;1-6(2)7(3,4)5/h;;(H,1,2)(H,3,4,5)/q2*+1;/p-2'], 'amounts': [], 'appearances': []}]","[{'chemical_names': ['title compound', 'N-Ethyl-5-(methylthio)-3-(trimethylsilyl)-2-thiophenecarboxamide'], 'identifiers': ['smiles:CCNC(=O)c1sc(SC)cc1[Si](C)(C)C', 'inchi:InChI=1S/C11H19NOS2Si/c1-6-12-11(13)10-8(16(3,4)5)7-9(14-2)15-10/h7H,6H2,1-5H3,(H,12,13)'], 'amounts': ['0.5 g', '88.2'], 'appearances': ['white']}]","[{'chemical_names': ['acetone'], 'identifiers': ['smiles:CC(C)=O', 'inchi:InChI=1S/C3H6O/c1-3(2)4/h1-2H3'], 'amounts': ['10 mL'], 'appearances': []}, {'chemical_names': ['CH2Cl2'], 'identifiers': ['smiles:ClCCl', 'inchi:InChI=1S/CH2Cl2/c2-1-3/h1H2'], 'amounts': [], 'appearances': []}]",[],"['step 1:To a solution of the compound of Example 260 (0.6 g) and NaI (0.8 g) in 10 mL acetone was added slowly 0.4 mL trifluoroacetic anhydride at 0° C.', 'step 1 properties:Temperature:0', 'step 2:the mixture was stirred at 0° C. for an additional hour', 'step 2 properties:Temperature:0', 'step 3:were added', 'step 4:The organic layer was separated', 'step 5:washed with brine', 'step 6:dried', 'step 7:concentrated', 'step 8:Flash chromatography of the residue with 10% ethyl acetate-hexane gave 0.5 g of the title compound as a white solid']"
